<DOC>
	<DOCNO>NCT00624065</DOCNO>
	<brief_summary>Randomized , double-blind , parallel group , multicenter study subject Stage 1 2 essential hypertension target blood pressure ( &lt; 140/90mmHg ) Baseline . Subjects randomize receive either carvedilol CR + lisinopril lisinopril + placebo . Subjects uptitrated 6 week period target blood pressure ( &lt; 140/90mmHg ) met . The primary objective study compare proportion subject achieve target blood pressure 6 week treatment .</brief_summary>
	<brief_title>Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>Male female age 1880 year ; stage 1 2 hypertension currently receive 0 1 antihypertensive medication ; mean sit systolic blood pressure &gt; /=140mmHg &lt; /=170mmHg , mean sit diastolic blood pressure &gt; /=90 &lt; /=105mmHg . Subjects take one hypertensive medication medication withdrawn enter washout phase prior randomization . Subject take two antihypertensive medication , know contraindication angiotensinconverting enzyme ( ACE ) inhibitor alpha betablocker therapy , subject Type 1 Type 2 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>target blood pressure</keyword>
	<keyword>hypertension</keyword>
	<keyword>COREG CR</keyword>
	<keyword>carvedilol CR</keyword>
	<keyword>Stage 1 2 essential hypertension</keyword>
	<keyword>lisinopril</keyword>
</DOC>